ThyTech | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

20 results for “ThyTech”

Trials

Cell Therapy With Treg Cells Obtained From Thymic Tissue (thyTreg) to Control the Immune Hyperactivation Associated With COVID-19 and/or Acute Respiratory Distress Syndrome (THYTECH2)

24 participants · First posted Sep 25, 2023

Drugs

TBA2 (GlyTech)

TBA1 (GlyTech)

Eryaspase (ERYtech Pharma)

Organizations

GlyTech, Inc.

Japan

Raytech Holding

BECKLEY PSYTECH LIMITED

United Kingdom

News

Major Treg Summit to Showcase Latest Advances in Autoimmune Disease Treatment Development

Regulatory Immune Cells Emerge as Key Therapeutic Targets in Immunotherapy and Autoimmune Disease Treatment

Beckley Psytech Announces Positive Results for ELE-101 in Depression Trial

Page 1 of 2